U.S. Markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
106.39+0.47 (+0.44%)
At close: 04:03PM EDT
106.54 +0.15 (+0.14%)
After hours: 07:59PM EDT

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908 740 4000

IndustryDrug Manufacturers—General
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert M. Davis J.D.CEO & Chairman4.4MN/A1967
Ms. Caroline LitchfieldExec. VP & CFO2.05M782.81k1969
Mr. Richard R. DeLuca Jr.Exec. VP & Pres of Merck Animal Health2.05M6.11M1963
Dr. Dean Y. Li M.D., Ph.D.Exec. VP & Pres of Merck Research Laboratories2.4MN/A1962
Mr. David Michael WilliamsExec. VP and Chief Information & Digital OfficerN/AN/A1969
Mr. Peter DannenbaumVP of Investor RelationsN/AN/AN/A
Ms. Jennifer L. ZacharyExec. VP & Gen. CounselN/AN/A1978
Lisa LeCointe-CephasSr. VP and Chief Ethics & Compliance OfficerN/AN/A1982
Ms. Cristal N. DowningExec. VP and Chief Communications & Public Affairs OfficerN/AN/A1970
Mr. Steven C. MizellExec. VP & Chief HR OfficerN/AN/A1960
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Corporate Governance

Merck & Co., Inc.’s ISS Governance QualityScore as of February 1, 2023 is 3. The pillar scores are Audit: 4; Board: 4; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.